Is Stem Cell Therapy FDA-Approved? 2 Key Facts Every Patient Needs to Understand

Stem cell therapy using allogeneic umbilical cord mesenchymal stem cells is not FDA-approved as a drug, biologic, or treatment for any specific condition. The FDA has not evaluated these therapies to diagnose, treat, cure, or prevent any disease. Responsibility for seeking this treatment and understanding its investigational status rests with the informed patient, within a legal framework established by Florida SB 1768.

Key Fact 1: What FDA Non-Approval Actually Means

The absence of FDA approval does not mean stem cell therapy is illegal or that it lacks scientific rationale. It means that the specific products have not completed the FDA's drug or biologic approval process, which requires large Phase 3 randomized controlled trials demonstrating safety and efficacy for a specific indication.

Many treatments in widespread use began without FDA approval. The FDA approval process is rigorous and expensive, creating a significant lag between emerging clinical evidence and formal approval. The scientific and clinical literature on mesenchymal stem cell therapy is substantial and growing, even without FDA approval as a specific product.

What FDA non-approval requires in practice: informed consent from the patient acknowledging the investigational status, physician supervision, and documentation of the clinical rationale for the individual patient.

Key Fact 2: Florida SB 1768 Provides the Legal Authorization

Florida Senate Bill 1768, effective July 1, 2025, establishes the legal framework under which non-FDA-approved stem cell therapies are authorized in Florida. The law requires 3 conditions: physician supervision by a Chapter 458 (MD) or Chapter 459 (DO) licensed physician, written informed consent acknowledging the investigational status, and an appropriate clinical setting.

At Rebuild Regen Medical Clinic, all 3 requirements are met. [MD_PLACEHOLDER] MD supervises all stem cell protocols. Written informed consent is obtained before every treatment. The clinic operates in a licensed medical office at 3320 N Federal Hwy #101, Lighthouse Point, FL 33064.

For more on SB 1768, see the Florida Stem Cell Law resource page.

When FDA Non-Approval Should Change a Patient's Decision

FDA non-approval should raise a patient's attention, not eliminate their options. The appropriate response is to ask more questions: Is the product from a certified source (AABB, cGMP, COA)? Is a physician supervising? Is informed consent being obtained properly? At Rebuild Regen, the answers to all three questions are yes.

A patient should not receive stem cell therapy from any provider who cannot document their biologics' source certifications, cannot produce a physician supervisor's credentials, and does not obtain written informed consent acknowledging the FDA non-approval status.